Literature DB >> 851642

Evidence for differentiation of human leukemic blood cells in diffusion chamber culture.

D Hoelzer, E Kurrle, H Schmücker, E B Harriss.   

Abstract

Peripheral blood cells of 21 patients with different forms of acute leukemia were cultured in diffusion chambers (5 x 10(5) cells/chamber) implanted intraperitoneally in 650 R preirradiated host mice over a period of up to 21 days. In patients with acute myeloid leukemia (AML), acute erythroleukemia (AEL), or acute myelomonocytic leukemia (AMMoL), the total number of cells which developed during this culture period exceeded the implanted value and also the values for normal peripheral blood cells from ten controls. In acute undifferentiated leukemia (AUL), two out of six patients showed considerable growth whereas the others, and also two patients with acute lymphoid leukemia (ALL), had poor growth. Differential counts revealed that the rise in total cells was due mainly to proliferation of blast cells and formation of granulopoietic cells. The latter exceeded the numbers from normal peripheral blood cells in 9 out of 13 patients with AML, AEL, or AMMoL and in 2 out of 6 patients with ALL. The production of granulopoiesis was not restricted to proliferating cells, but included mature cells which were of abnormal morphology in some cases. From the amount of granulopoiesis and the time of its development it was assumed that they were at least partly derived from leukemic blast cells. Chromosome analyses to decide whether the granulopoietic cells were of leukemic or normal cell origin are in progress.

Entities:  

Mesh:

Year:  1977        PMID: 851642

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

1.  Cell surface differentiation of acute lymphoblastic call-type leukemias in diffusion chambers.

Authors:  G Jäger; B Lau; K Pachmann; H Rodt; B Netzel; E Thiel; D Huhn; S Thierfelder; P Dörmer
Journal:  Blut       Date:  1979-02-19

2.  The in vivo diffusion chamber technique for bone marrow or blood cell culture.

Authors:  R Willemze; R I Walker
Journal:  Blut       Date:  1981-02

Review 3.  Treatment strategies in acute myeloid leukemia (AML). B. Second line treatment.

Authors:  W Hiddemann; T Büchner
Journal:  Blut       Date:  1990-03

4.  Auer-rod positive myelocytic leukemia cells in diffusion chambers: differentiation along the eosinophilic pathway.

Authors:  B Lau; G Jäger; D Huhn; U Jehn; S Thierfelder; P Dörmer
Journal:  Blut       Date:  1982-11

5.  Appearance of B- or T-lymphocyte markers after diffusion chamber culture of acute lymphoblastic leukemia cells.

Authors:  E Thiel; B Lau; H Rodt; G Jäger; K Pachmann
Journal:  Blut       Date:  1981-05

6.  Growth and differentiation patterns of human acute non lymphoid leukemia in diffusion chambers before and after treatment.

Authors:  T Izzi; A Fontebuoni; G Lucarelli
Journal:  Blut       Date:  1981-07

7.  Low-dose Ara-C in the treatment of acute leukemia. Cytotoxicity or differentiation induction?

Authors:  D Hoelzer; A Ganser; B Anger; E Seifried; H Heimpel
Journal:  Blut       Date:  1984-04

8.  Prognostic value of in vitro growth pattern of colony forming cells in adult acute leukaemia.

Authors:  U Jehn; D Kern; K Wachholz; D Hölzel
Journal:  Br J Cancer       Date:  1983-03       Impact factor: 7.640

9.  Patterns of maturation in short-term culture of human acute myeloid leukaemic cells.

Authors:  G Palú; R Powles; P Selby; B M Summersgill; P Alexander
Journal:  Br J Cancer       Date:  1979-11       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.